ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Panel Waffles On One Vs. Three Year Intervals For Pap Test, Agrees On when They Should Start

August 1, 1980

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

In Brief: NIH Minority Program Model For Universities, Califano Says; viral Oncology Move Dropped

February 25, 1977

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

NCI CTEP Approved Trials For the Month of January

January 31, 2014